Zhejiang Hongyu Medical Technology Co., Ltd., founded in 2019 with a registered capital of CNY 10 million, is the world's first company to develop R & D of mitral regurgitation medical devices for pet dogs. The core product is an independently developed mitral valve interventional repair device V-Clamp, and the technology of this product comes from Shanghai Hanyu Medical Technology Co., Ltd.
In 2020, the company has received 30 million RMB in the angel round financing, led by CITIC Fund and LYZZ Capital. Nearly 10,000 square meters of R & D base and plant construction, located in Hangzhou, are going to be built. Adhering to the concept of innovation and pioneering, with the mission of benefiting pets' lives, the company strives to become a global leader in the field of pet cardiac treatment.
Zhejiang Hongyu Medical Technology Co., Ltd
103 Lane 125, Weidu Road
Shanghai, Shanghai 201109 China (People's Republic)